Volume 28, Issue 129 (July & August 2020)                   J Adv Med Biomed Res 2020, 28(129): 183-190 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mirasheh M H, Zohrehvand M R, Kazemi R, Bahari Z, Bahrami F, Jangravi Z et al . The Analgesic and Anxiolytic Activity of Resveratrol Mediated by Different Sub-Types of α-Adrenoceptors of Anterior Cingulate Cortex Following Neuropathic Pain in Male Rats. J Adv Med Biomed Res 2020; 28 (129) :183-190
URL: http://journal.zums.ac.ir/article-1-5914-en.html
The Analgesic and Anxiolytic Activity of Resveratrol Mediated by Different Sub-Types of α-Adrenoceptors of Anterior Cingulate Cortex Following Neuropathic Pain in Male Rats
Mohammad Hassan Mirasheh1 , Mohammad Reza Zohrehvand1 , Reza Kazemi1 , Zahra Bahari * 2, Farideh Bahrami3 , Zohreh Jangravi4 , Mehdi Graily3
1- Students Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Dept. of Physiology and Medical Physics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran , bahari_441@yahoo.com
3- Dept. of Physiology and Medical Physics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
4- Dept. of Biochemistry, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
Abstract:   (146358 Views)

Background and Objective: The mechanism of analgesic and anxiolytic activity of resveratrol in neuropathic pain conditions remains obscure. The present study was conducted to examine whether the analgesic and anxiolytic activities of resveratrol are associated with α1- and α2-adrenoceptors of the anterior cingulate cortex (ACC), which is a key area of the cortex in the pain process, following neuropathic pain in rats.
Materials and Methods: Neuropathic pain was created by chronic constriction injury (CCI) of the sciatic nerve. Male Wistar rats were assigned to the sham, CCI, CCI+resveratrol (40μg/5μL), CCI+resveratrol+prazosin (α1-adrenoceptor antagonist,30μg/5μL), and CCI+resveratrol-Yohimbine (α2-adrenoceptor antagonist, 30μg/5μL) groups. The rats received intra-ACC injection of the drug on the day of CCI and for 6 days post-CCI on a daily basis. Cold allodynia (using acetone test) and anxiety (using elevated plus maze, EPM) were examined on days 2, 4, and 6 following CCI.
Results: CCI model significantly increased cold allodynia and anxiety. Resveratrol significantly decreased cold allodynia. Prazosin induced no significant changes in allodynia as compared with the CCI+resveratrol treated group. But the animals in this group had no significant difference from the day before the surgery or compared with the sham group. Prazosin significantly decreased entries into open arms. Additionally, yohimbine significantly increased cold allodynia as compared with the CCI+resveratrol treated group. However, it induced no significant changes in the EPM parameters. Our findings also demonstrated a significant correlation between allodynia and anxiety in CCI rats.
Conclusion: It is suggested that the mechanism of analgesic and anxiolytic activities of resveratrol in the ACC of rats is different, and is mediated through α2- and α1-adrenoceptors, respectively.

Keywords: Allodynia, Anxiety, Anterior cingulate cortex, α-adrenoceptors, Rat, Resveratrol
Full-Text [PDF 414 kb]   (155734 Downloads) |   |   Full-Text (HTML)  (3775 Views)  

✅ It is suggested that the mechanism of analgesic and anxiolytic activities of resveratrol in the ACC of rats is different, and is mediated through α2- and α1-adrenoceptors, respectively.


Type of Study: Original Article | Subject: Medical Biology
Received: 2020/01/27 | Accepted: 2020/07/7 | Published: 2020/08/11
References
1. Alles SR, Smith PA. Etiology and Pharmacology of Neuropathic Pain. Pharmacol Rev. 2018; 70(2):315-47. [DOI:10.1124/pr.117.014399]
2. Bahari Z, Sadr SS, MeftahiGH,et al. Nerve injury-induced plasticity in the nociceptive pathways. Arch Neurosci. 2015; 2(2):e18214. [DOI:10.5812/archneurosci.18214]
3. Ferreira-Chamorro P, Redondo A, Riego G, Leanez S, Pol O. Sulforaphane inhibited the nociceptive responses, anxiety- and depressive-like behaviors associated with neuropathic pain and improved the anti-allodynic effects of morphine in mice. Front Pharmacol. 2018; 9: 1332. [DOI:10.3389/fphar.2018.01332]
4. Chen H, Hu Y, XieK,et al. Effect of autophagy on allodynia, hyperalgesia and astrocyte activation in a rat model of neuropathic pain. Int J Mol Med. 2018; 42:2009-19. [DOI:10.3892/ijmm.2018.3763]
5. Vakili A, Shirvanian MJ, Safakhah HA, Rashidy-Pour A. Pentoxifylline decreases allodynia and hyperalgesia in a rat model of neuropathic pain. Daru. 2011; 19(4):306-11.
6. Bahari Z, Meftahi GH. Spinal α2‐adrenoceptors and neuropathic pain modulation; therapeutic target. Br J Pharmacol. 2019; 176(14):2366-81. [DOI:10.1111/bph.14580]
7. Sudo RT, do Amaral RV, da Silva MonteiroCE,et al. Antinociception induced by a novel α2A adrenergic receptor agonist in rodents acute and chronic pain models. Eur J Pharmacol. 2017; 815:210-18. [DOI:10.1016/j.ejphar.2017.09.018]
8. Kubre J, Sethi A, Mahobia M, Bindal D, Narang N, Saxena A. Single dose intravenous dexmedetomidine prolongs spinal anesthesia with hyperbaric bupivacaine. Anesth Essays Res. 2016; 10:273-77. [DOI:10.4103/0259-1162.174465]
9. Sudo RT, Calasans-Maia JA, GaldinoSL,et al. Interaction of morphine with a new alpha2-adrenoceptor agonist in mice. J Pain. 2010; 11:71-8. [DOI:10.1016/j.jpain.2009.08.001]
10. Roh DH, Kim HW, Yoon SY,et al. Intrathecal clonidine suppresses phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit in spinal dorsal horn neurons of rats with neuropathic pain. AnesthAnalg. 2008; 107(2):693-700. [DOI:10.1213/ane.0b013e31817e7319]
11. Liang F, Liu M, Fu X, Zhou X, Chen P, Han F. Dexmedetomidine attenuates neuropathic pain in chronic constriction injury by suppressing NR2B, NF-κB, and iNOS activation. Saudi Pharm J. 2017; 25(4):649-54. [DOI:10.1016/j.jsps.2017.04.039]
12. Chia JS, Mohammed Izham NA, Farouk AA,et al. Zerumbone modulates α2A-adrenergic, TRPV1, and NMDA NR2B receptors plasticity in CCI-induced neuropathic pain in vivo and LPS-induced SH-SY5Y neuroblastoma in vitro models. Front Pharmacol. 2020; 11: 92. [DOI:10.3389/fphar.2020.00092]
13. Fuchs PN, Peng YB, Boyette-Davis JA, Uhelski ML. The anterior cingulate cortex and pain processing. Front IntegrNeurosci. 2014; 8:35. [DOI:10.3389/fnint.2014.00035]
14. Xiao Z, Martinez E, Kulkarni PM,et al. Cortical pain processing in the rat anterior cingulate cortex and primary somatosensory cortex. Front Cell Neurosci. 2019; 13: 165. [DOI:10.3389/fncel.2019.00165]
15. Fuchs PN, Peng YB, Boyette-Davis JA, Uhelski ML. The anterior cingulate cortex and pain processing. Front IntegNeurosci. 2014; 8: 35. [DOI:10.3389/fnint.2014.00035]
16. Tao L, Ding Q, Gao C, Sun X. Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. IntImmunopharmacol. 2016; 34:165-72. [DOI:10.1016/j.intimp.2016.02.033]
17. Cheng W, Zhao Y, Liu H, et al. Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation. Fund ClinPharmacol. 2014; 28:661-70. [DOI:10.1111/fcp.12084]
18. Maia H, Haddad C, Pinheiro N, Casoy J. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. Int J Women's Health. 2012; 4:543-49. [DOI:10.2147/IJWH.S36825]
19. Tili E, Michaille JJ. Resveratrol, microRNAs, inflammation, and cancer. J Nucleic Acids. 2011; (2011):102431. [DOI:10.4061/2011/102431]
20. MoiniZanjani T, Ameli H, Labibi F, Sedaghat K, Sabetkasaei M. The attenuation of pain behavior and serum COX-2 concentration by Curcumin in a rat model of neuropathic pain. Korean J Pain. 2014; 27(3): 246-52. [DOI:10.3344/kjp.2014.27.3.246]
21. Um SW, Kim MJ, Leem JW, Bai SJ, Lee BH. Pain-relieving effects of mTOR inhibitor in the anterior cingulate cortex of neuropathic rats. MolNeurobiol. 2019; 56(4):2482-94. [DOI:10.1007/s12035-018-1245-z]
22. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988; 33:87-107. [DOI:10.1016/0304-3959(88)90209-6]
23. Choi Y, Yoon YW, Na HS, Kim SH, Chung JM. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 1994; 59:369-76. [DOI:10.1016/0304-3959(94)90023-X]
24. Akçali D, Belen AD, Babacan A, Bolay H. Nitroglycerin challenge induces lateralized headache in nasociliary nerve-ligated rats: implications for chronic migraine. Turk J Med Sci. 2017; 47:681-88. [DOI:10.3906/sag-1602-86]
25. Austin PJ, Wu A, Moalem-Taylor G. Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats. J Vis Exp. 2012; 61: 3393. [DOI:10.3791/3393]
26. Sadeghi M, Manaheji H, Haghparast A, Zaringhalam J, Nazemi S, Bahari Z. Study of the effect of GABAA receptor and glial inhibition on behavioral responses in CCI model of neuropathic pain in rat. Iran South Med Journal .2015; 17(6):1120-34.
27. Murasawa H, Kobayashi H, Saeki K, Kitano Y. Anxiolytic effects of the novel α2δ ligand mirogabalin in a rat model of chronic constriction injury, an experimental model of neuropathic pain. Psychopharmacol.2020;237(1):189-197. [DOI:10.1007/s00213-019-05356-3]
28. Berrocoso E, Mico JA, Vitton O, et al.Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain. Eur J Pharmacol. 2011; 655(1-3):46-51. [DOI:10.1016/j.ejphar.2011.01.022]
29. Gambeta E, Batista MA, Maschio GP, Turnes JM, Araya EI, Chichorro JG. Anxiety- but not depressive-like behaviors are related to facial hyperalgesia in a model of trigeminal neuropathic pain in rats. PhysiolBehav. 2018; 191:131-7. [DOI:10.1016/j.physbeh.2018.04.025]
30. Abbaszadeh A, Darabi S, HasanvandA,et al. Minocycline through attenuation of oxidative stress and inflammatory response reduces the neuropathic pain in a rat model of chronic constriction injury. Iran J Basic Med Sci. 2018; 21(2):138-44.
31. Roeska K, Doods H, Arndt K, Treede RD, Ceci A. Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin. Pain. 2009; 139:349-57. [DOI:10.1016/j.pain.2008.05.003]
32. Şahin TD, Göçmez SS, Eraldemir FC, Utkan T. Anxiolytic-like and antidepressant-like effects of resveratrol in streptozotocin-induced diabetic rats. NoroPsikiyatrArs. 2019; 56(2): 144-49.
33. Takehana S, Sekiguchi K, Inoue M,et al. Systemic administration of resveratrol suppress the nociceptive neuronal activity of spinal trigeminal nucleus caudalis in rats. Brain Res Bull. 2016; 120:117-22. [DOI:10.1016/j.brainresbull.2015.11.011]
34. Xie JY, Liu S, Wu B,et al. The protective effect of resveratrol in the transmission of neuropathic pain mediated by the P2X7 receptor in the dorsal root ganglia. Neurochem Int. 2017; 103:24-35. [DOI:10.1016/j.neuint.2016.12.006]
35. Yin Q, Lu FF, Zhao Y,et al. Resveratrol facilitates pain attenuation in a rat model of neuropathic pain through the activation of spinal sirt1. RegAnesth Pain Med. 2013; 38: 93Y99. [DOI:10.1097/AAP.0b013e3182795b23]
36. Xu M, Cheng Z, Ding Z, Wang Y, Guo Q, Huang C. Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in spinal cord and attenuates neuropathic pain following sciatic nerve injury. Mol Pain. 2018; 14: 1-11. [DOI:10.1177/1744806918767549]
37. Zhao R, Zhou H, Huang L, et al.Neuropathic pain causes pyramidal neuronal hyperactivity in the anterior cingulate cortex. Front Cell Neurosci. 2018; 12:107. [DOI:10.3389/fncel.2018.00107]
38. Obata H. Analgesic mechanisms of antidepressants for neuropathic pain. Int J Mol Sci. 2017; 18(11): E2483. [DOI:10.3390/ijms18112483]
39. Koga K, Yamada A, Song Q,et al. Ascending noradrenergic excitation from the locus coeruleus to the anterior cingulate cortex. Mol Brain. 2020; 13:49. [DOI:10.1186/s13041-020-00586-5]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb